Share-based compensation - Options (Details) - $ / shares |
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 01, 2023 |
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
|
Number of options over ordinary shares granted (in shares) | 30,247,398 | 1,735,488 | 52,002,726 | 24,611,952 | |
Weighted average fair value of ordinary shares options (in dollars per share) | $ 0.05 | $ 0.25 | $ 0.08 | $ 0.41 | |
Number of additional options with a nominal exercise price granted | 6,148,186 | 3,361,728 | 26,015,098 | 21,050,160 | |
Weighted average fair value of options with a nominal exercise price | $ 0.15 | $ 0.34 | $ 0.17 | $ 0.55 | |
Replacement Awards Granted To TCR2 Grantholders | |||||
Number of options over ordinary shares granted (in shares) | 29,654,742 | ||||
Number of additional options with a nominal exercise price granted | 5,501,602 |
X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. No definition available.
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted with nominal exercise price during the period. No definition available.
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|